These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6483571)

  • 1. Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.
    Vree TB; Hekster YA; Tijhuis MW; Baakman M; Oosterbaan MJ; Termond EF
    Pharm Weekbl Sci; 1984 Aug; 6(4):150-6. PubMed ID: 6483571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the molecular structure of closely related N1-substituents of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and renal clearance related to the structure of sulfadiazine, sulfamerazine and sulfadimidine.
    Vree TB; Hekster YA; Tijhuis MW; Baakman M; Janssen TJ; Termond EF
    Pharm Weekbl Sci; 1983 Apr; 5(2):49-56. PubMed ID: 6866714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfamethomidine in humans.
    Vree TB; Beneken Kolmer EW; Hekster YA
    Pharm Weekbl Sci; 1991 Oct; 13(5):198-206. PubMed ID: 1749708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tubular excretion of the N4-acetyl metabolites of sulphasomidine and sulphadimethoxine in the dog.
    Boom SP; Wouterse AC; Vree TB; Van Ginneken CA; Russel FG
    J Pharm Pharmacol; 1993 Jul; 45(7):614-7. PubMed ID: 8105055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resorption and elimination of N4-substituted sulfanilamides in rats].
    Funk KF; Oelssner W; Meyer FP
    Pharmazie; 1970 Sep; 25(9):554-6. PubMed ID: 5486684
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfadimethoxine in man.
    Vree TB; Beneken Kolmer EW; Martea M; Bosch R; Hekster YA; Shimoda M
    Pharm Weekbl Sci; 1990 Apr; 12(2):51-9. PubMed ID: 2336339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, acetylation-deacetylation, renal clearance, and protein binding of sulphamerazine, N4-acetylsulphamerazine, and N4-trideuteroacetylsulphamerazine in 'fast' and 'slow' acetylators.
    Vree TB; Hekster CA; Baakman M; Janssen T; Oosterbaan M; Termond E; Tijhuis M
    Biopharm Drug Dispos; 1983; 4(3):271-91. PubMed ID: 6626702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of protein binding on the excretion of some sulphanilamidopyrimidines in man.
    Walker SR
    J Pharm Pharmacol; 1970 Aug; 22(8):574-7. PubMed ID: 4394530
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of plasma protein binding on the metabolism and renal excretion of sulphadimethoxine and its metabolite N4-acetylsulphadimethoxine in pigs.
    Shimoda M; Vree TB; Beneken Kolmer EW; Arts TH
    Vet Q; 1990 Apr; 12(2):87-97. PubMed ID: 2363242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion.
    Vree TB; Hekster YA; Damsma JE; Tijhuis M; Friesen WT
    Eur J Clin Pharmacol; 1981; 20(4):283-92. PubMed ID: 7308281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of hydrolysis of N4-substituted sulfanilamides in vivo].
    Funk KF; Oelssner W
    Pharmazie; 1970 Sep; 25(9):557-60. PubMed ID: 4098821
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics, metabolism and renal excretion of sulfatroxazole and its 5-hydroxy- and N4-acetyl-metabolites in man.
    Vree TB; Hekster YA; Tijhuis MW; Termond EF; Nouws JF
    Biopharm Drug Dispos; 1986; 7(3):239-52. PubMed ID: 3730524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal excretion of sulphanilamide, sulphadimidine, sulphadoxine and sulphamethoxazole in goats].
    Jorgensen ST; Rasmussen F
    Nord Vet Med; 1972 Dec; 24(12):601-11. PubMed ID: 4666500
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism and binding of N-(2-methyl-6-methoxy-4-pyrimidinyl) sulfanilamide (sulfamethomidine) in man.
    DICARLO FJ; MALAMENT SG; HAYNES LJ; PHILLIPS GE
    Toxicol Appl Pharmacol; 1963 Jan; 5():61-70. PubMed ID: 14027680
    [No Abstract]   [Full Text] [Related]  

  • 15. KINETICS OF THE ACETYLATION AND EXCRETION OF SULFONAMIDES AND A COMPARISON OF TWO MODELS.
    NELSON E
    Antibiot Chemother; 1964; 12():29-40. PubMed ID: 14262397
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.
    Vree TB; O'Reilly WJ; Hekster YA; Damsma JE; van der Kleijn E
    Clin Pharmacokinet; 1980; 5(3):274-94. PubMed ID: 7389236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IN VITRO SENSITIVITY OF ESCHERICHIA COLI TO SULFONAMIDES.
    GLANTZ PJ
    Cornell Vet; 1965 Jan; 55():9-18. PubMed ID: 14284453
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of sulfanilamides in the body].
    Reimerdes E; Thumim JH
    Arzneimittelforschung; 1970 Sep; 20(9):1171-9. PubMed ID: 4922318
    [No Abstract]   [Full Text] [Related]  

  • 19. MANAGEMENT ACUTE PYELONEPHRITIS.
    SMYTHE CM
    Mod Treat; 1964 Jan; 1():63-77. PubMed ID: 14161717
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and renal clearance of sulphadimidine, sulphamerazine and sulphadiazine and their N4-acetyl and hydroxy metabolites in pigs.
    Nouws JF; Mevius D; Vree TB; Degen M
    Vet Q; 1989 Apr; 11(2):78-86. PubMed ID: 2741297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.